Primer: GI Cell (GICELL KS) - May 2026
GI Cell is a clinical-stage biotechnology company at the forefront of developing 'off-the-shelf' allogeneic Natural Killer (NK) cell therapies,...
84 Views
No more insights
𝛼SK or SearchENTITY
GI Cell (GICELL KS)
GI Cell (GICELL KS)
1
Analysis
Health Care • South Korea
The company develops immune cell-based therapeutics and vaccines for the treatment of cancer, inflammatory disorders, and infectious diseases. Its platform technology optimizes ancillary proteins for target immune cells and engineers multi-valent sub-unit vaccines, providing medical practitioners with specialized solutions for complex disease management.
morex